The European Society of Cardiology and the European Association of Percutaneous Cardiovascular Interventions issued a consensus statement in March 2023 stating that renal sympathetic denervation can be used as adjunctive therapy for patients with uncontrolled hypertension who have had inadequate responses to medications and lifestyle changes.
